candesartan has been researched along with Liver Neoplasms in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan was able to reverse this process in a dose-dependent manner." | 5.43 | Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway. ( Fan, F; Jiang, G; Liu, Z; Lu, Y; Shen, C; Tao, L; Tian, C; Wu, H, 2016) |
| "Candesartan was able to reverse this process in a dose-dependent manner." | 1.43 | Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway. ( Fan, F; Jiang, G; Liu, Z; Lu, Y; Shen, C; Tao, L; Tian, C; Wu, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, F | 1 |
| Tian, C | 1 |
| Tao, L | 1 |
| Wu, H | 1 |
| Liu, Z | 1 |
| Shen, C | 1 |
| Jiang, G | 1 |
| Lu, Y | 1 |
| Wasa, J | 1 |
| Sugiura, H | 1 |
| Kozawa, E | 1 |
| Kohyama, K | 1 |
| Yamada, K | 1 |
| Taguchi, O | 1 |
2 other studies available for candesartan and Liver Neoplasms
| Article | Year |
|---|---|
Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Carcinoma, Hep | 2016 |
The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Blo | 2011 |